Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil: A Population-based Study

NCT04326504 is registered in ClinicalTrials.gov with Fundação Bahiana de Infectologia as lead sponsor.

NCT NCT04326504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04326504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil: A Population-based Study
Lead sponsor
Fundação Bahiana de Infectologia
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2021
Completion date
February 28, 2025
Enrollment
5,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, clinical outcomes, effect of drugs, hiv infections